Schedule 13G ownership disclosure

DIFFUSION PHARMACEUTICALS IN

Security class unavailable · CUSIP: 253748206

Event date: 2017-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-112092
Form type
SC 13G/A
Filer
Ally Bridge Group Capital Partners II, L.P.
CIK
CIK 1609313
Filed
Apr 06, 2017
Reporting period
Mar 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G/A | SEC Filings Hub